Undifferentiated Symptoms — MCQs
On this page
A 56-year-old woman presents with a 10-week history of unintentional weight loss of 5kg and fatigue. She reports no specific gastrointestinal symptoms but notes occasional abdominal discomfort. Examination reveals a palpable mass in the right upper quadrant. Blood tests show Hb 118 g/L, platelets 450 × 10⁹/L, albumin 32 g/L, ALP 180 U/L, ALT 65 U/L, and CA 19-9 significantly elevated. What is the most appropriate next investigation?
A 49-year-old woman with metastatic breast cancer presents for review of pain management. She reports severe bone pain (8/10) despite taking morphine sulfate modified-release 60mg twice daily and paracetamol 1g four times daily. She is using 4-6 doses of oral morphine 10mg (breakthrough analgesia) daily. She experiences no significant side effects from current medication. What is the most appropriate modification to her pain management regimen?
A 55-year-old woman presents with a 15-week history of fatigue and widespread musculoskeletal pain. She describes morning stiffness in her hands lasting 30 minutes, and pain particularly affecting the small joints of her hands and feet. Examination reveals swelling of the MCP and PIP joints bilaterally with tenderness. Blood tests show: Hb 108 g/L, CRP 34 mg/L, ESR 42 mm/hr, rheumatoid factor negative, anti-CCP negative. What is the most appropriate management?
A 67-year-old woman presents with an 11-week history of progressive fatigue, 7kg weight loss, and fever ranging from 37.8-38.6°C. She reports severe bilateral shoulder and hip girdle pain and stiffness, worst in the morning and lasting >1 hour. Examination shows limited active but full passive range of movement in shoulders. Blood tests show: Hb 102 g/L, ESR 88 mm/hr, CRP 92 mg/L, ALP 156 U/L (normal 30-130), normal calcium. What is the most critical next step in management?
A 38-year-old woman presents with a 14-week history of widespread pain affecting her neck, shoulders, back, and thighs, associated with severe fatigue and unrefreshing sleep. Pain intensity fluctuates between 5-8/10. She also reports memory problems and frequent headaches. Examination shows multiple tender points but no joint swelling or neurological deficit. Blood tests including FBC, CRP, ESR, TFTs, CK, and vitamin D are all normal. Which additional assessment tool is most appropriate to support diagnosis and guide management?
A 71-year-old man presents with a 12-week history of lower back pain radiating to both legs, associated with difficulty walking more than 50 metres. The pain is worse when walking and relieved by sitting or leaning forward. He describes numbness in his feet and reports recent urinary hesitancy. Neurological examination shows preserved power but reduced sensation in L5/S1 distribution bilaterally and absent ankle reflexes. What is the most likely diagnosis?
A 52-year-old man with no significant medical history presents with a 6-week history of fever (documented temperatures 38.3-39.1°C), generalized myalgia, and a 5kg weight loss. Examination reveals no focal abnormalities. Initial blood tests show: Hb 108 g/L, WCC 11.2 x10⁹/L (neutrophils 8.1), CRP 78 mg/L, ESR 62 mm/hr. Blood cultures, urinalysis, and chest X-ray are normal. What is the most appropriate next investigation to arrange from primary care?
A 47-year-old woman presents with a 16-week history of profound fatigue, generalized aching, and cognitive difficulties ('brain fog'). Symptoms began after a documented COVID-19 infection. She has been unable to return to work. Examination and routine blood tests (FBC, U&E, LFTs, TFTs, CRP, glucose, ferritin) are all normal. She becomes breathless and experiences worsening fatigue for several days after minimal physical activity. What is the most appropriate management approach?
A 36-year-old refugee from Sudan presents with a 10-week history of daily fever up to 38.9°C, 8kg weight loss, night sweats, and dry cough. He arrived in the UK 4 months ago. Chest examination reveals reduced breath sounds at the right apex. Chest X-ray shows right upper lobe consolidation with cavitation. What is the most appropriate immediate management while awaiting confirmation of diagnosis?
According to current NICE guidance, what is the recommended threshold for urgent direct access chest X-ray in adults presenting with unexplained weight loss in primary care?
Undifferentiated Symptoms UK Medical PG Practice Questions and MCQs
Question 81: A 56-year-old woman presents with a 10-week history of unintentional weight loss of 5kg and fatigue. She reports no specific gastrointestinal symptoms but notes occasional abdominal discomfort. Examination reveals a palpable mass in the right upper quadrant. Blood tests show Hb 118 g/L, platelets 450 × 10⁹/L, albumin 32 g/L, ALP 180 U/L, ALT 65 U/L, and CA 19-9 significantly elevated. What is the most appropriate next investigation?
- A. CT scan of abdomen and pelvis with contrast (Correct Answer)
- B. Upper gastrointestinal endoscopy
- C. Colonoscopy
- D. Ultrasound scan of abdomen
- E. Chest X-ray
Explanation: ***CT scan of abdomen and pelvis with contrast*** - The combination of **unintentional weight loss**, a **palpable right upper quadrant mass**, elevated **ALP** and **ALT**, and significantly raised **CA 19-9** strongly indicates a **pancreatic or hepatobiliary malignancy**. - A **contrast-enhanced CT scan** is the most appropriate next investigation as it provides comprehensive anatomical information for **diagnosis**, **staging**, and assessing **resectability** of such tumors. *Upper gastrointestinal endoscopy* - This procedure is primarily indicated for evaluating conditions affecting the **esophagus**, **stomach**, or **duodenum**, such as ulcers or tumors. - While abdominal discomfort is present, it would not effectively visualize a mass in the **pancreas**, **biliary tree**, or **retroperitoneum**, which are highly suspected here. *Colonoscopy* - Colonoscopy is the gold standard for investigating **colorectal pathology**, typically for symptoms like altered bowel habits, rectal bleeding, or iron-deficiency anemia. - The patient's presentation with an **RUQ mass** and elevated **CA 19-9** makes primary colorectal cancer less likely as the immediate cause. *Ultrasound scan of abdomen* - An ultrasound can be useful for initial assessment of the liver, gallbladder, and kidneys but often has limited sensitivity for detailed visualization of the **pancreas** due to **overlying bowel gas**. - Given the strong suspicion of malignancy and the need for accurate **staging**, a **CT scan** is superior for a definitive diagnosis and treatment planning. *Chest X-ray* - A chest X-ray is typically performed to evaluate for **pulmonary metastases** once a primary malignancy has been identified and localized. - It would not provide any diagnostic information regarding the **primary abdominal mass** itself, making it an unsuitable *first* diagnostic investigation in this context.
Question 82: A 49-year-old woman with metastatic breast cancer presents for review of pain management. She reports severe bone pain (8/10) despite taking morphine sulfate modified-release 60mg twice daily and paracetamol 1g four times daily. She is using 4-6 doses of oral morphine 10mg (breakthrough analgesia) daily. She experiences no significant side effects from current medication. What is the most appropriate modification to her pain management regimen?
- A. Increase modified-release morphine to 90mg twice daily and breakthrough dose to 15mg (Correct Answer)
- B. Add ibuprofen 400mg three times daily to current opioid regimen
- C. Switch to transdermal fentanyl patch 50 micrograms/hour every 72 hours
- D. Add gabapentin 300mg at night, titrating to 300mg three times daily
- E. Increase breakthrough morphine dose to 20mg while maintaining background analgesia
Explanation: ***Increase modified-release morphine to 90mg twice daily and breakthrough dose to 15mg*** - Frequent breakthrough pain (4-6 doses daily) indicates inadequate **background analgesia**; the total daily morphine intake (current 120mg MR + 40-60mg breakthrough = 160-180mg) must be consolidated into the **regular dosing schedule**. - The correct titration involves increasing the **modified-release (MR)** dose (e.g., by 25-50% from the current dose or by consolidating breakthrough opioid use) and recalculating the **breakthrough dose** to be approximately **1/6th to 1/10th** of the new total 24-hour dose. *Add ibuprofen 400mg three times daily to current opioid regimen* - While **NSAIDs** are effective for **metastatic bone pain** (WHO ladder Step 2 addition), they do not address the immediate need to titrate the already established opioid dose for this level of severe pain. - Simply adding ibuprofen would be insufficient when the patient is requiring high-frequency **breakthrough morphine** doses daily, indicating a need for higher opioid baseline. *Switch to transdermal fentanyl patch 50 micrograms/hour every 72 hours* - **Transdermal fentanyl** is generally reserved for patients with **stable pain** requirements who cannot tolerate oral medications or for convenience; it is difficult to titrate in acute pain escalation. - Switching to a different opioid (**opioid rotation**) is not indicated here as the patient is not experiencing **toxicity** or significant **side effects** from morphine. *Add gabapentin 300mg at night, titrating to 300mg three times daily* - This patient describes **bone pain**, which is typically **nociceptive**; **gabapentin** is indicated for **neuropathic pain**, characterized by burning, shooting, or electric-shock sensations. - Adding an adjuvant for the wrong pain type will not resolve the **inadequate opioid titration** for her nociceptive metastatic pain. *Increase breakthrough morphine dose to 20mg while maintaining background analgesia* - Increasing only the **breakthrough dose** without adjusting the **background dose** leads to erratic pain control and does not provide constant analgesia. - Standard palliative care practice dictates that if more than **two doses** of breakthrough analgesia are needed daily, the **modified-release dose** should be increased.
Question 83: A 55-year-old woman presents with a 15-week history of fatigue and widespread musculoskeletal pain. She describes morning stiffness in her hands lasting 30 minutes, and pain particularly affecting the small joints of her hands and feet. Examination reveals swelling of the MCP and PIP joints bilaterally with tenderness. Blood tests show: Hb 108 g/L, CRP 34 mg/L, ESR 42 mm/hr, rheumatoid factor negative, anti-CCP negative. What is the most appropriate management?
- A. Diagnose seronegative inflammatory arthritis and start sulfasalazine
- B. Reassure that negative antibodies exclude inflammatory arthritis and manage symptomatically
- C. Refer urgently to rheumatology for assessment within 3 working days (Correct Answer)
- D. Start prednisolone 15mg daily pending rheumatology review
- E. Repeat rheumatoid factor and anti-CCP in 3 months to confirm diagnosis
Explanation: ***Refer urgently to rheumatology for assessment within 3 working days***- The patient's clinical presentation, including **symmetric synovitis** of the MCP and PIP joints, morning stiffness lasting >30 minutes, and duration >6 weeks, strongly suggests **inflammatory arthritis**, even with negative serology. - Early referral to rheumatology (within 3 working days for suspected inflammatory arthritis with objective synovitis) is crucial to facilitate timely diagnosis and initiation of **disease-modifying antirheumatic drugs (DMARDs)**, which significantly impacts long-term outcomes and prevents joint damage.*Diagnose seronegative inflammatory arthritis and start sulfasalazine*- While the clinical picture is consistent with **seronegative inflammatory arthritis**, the definitive diagnosis and initiation of specific **DMARDs** like sulfasalazine should be managed by a rheumatologist, not primary care.- Starting DMARDs without specialist confirmation can lead to misdiagnosis, inappropriate treatment, and potential side effects.*Reassure that negative antibodies exclude inflammatory arthritis and manage symptomatically*- This approach is incorrect as approximately 20-30% of patients with **rheumatoid arthritis** are **seronegative** (negative RF and anti-CCP), but still have significant disease requiring early treatment.- Reassurance and symptomatic management alone would delay appropriate treatment, increasing the risk of **irreversible joint damage** and functional impairment.*Start prednisolone 15mg daily pending rheumatology review*- Initiating **corticosteroids** in primary care can mask the clinical signs of **synovitis**, making the assessment and definitive diagnosis more challenging for the rheumatologist.- While sometimes used as a short-term
Question 84: A 67-year-old woman presents with an 11-week history of progressive fatigue, 7kg weight loss, and fever ranging from 37.8-38.6°C. She reports severe bilateral shoulder and hip girdle pain and stiffness, worst in the morning and lasting >1 hour. Examination shows limited active but full passive range of movement in shoulders. Blood tests show: Hb 102 g/L, ESR 88 mm/hr, CRP 92 mg/L, ALP 156 U/L (normal 30-130), normal calcium. What is the most critical next step in management?
- A. Start prednisolone 15mg daily and review response in 1 week
- B. Arrange urgent temporal artery ultrasound within 7 days
- C. Request urgent temporal artery biopsy before starting steroids
- D. Commence prednisolone 40-60mg daily immediately and arrange same-day ophthalmology assessment (Correct Answer)
- E. Request urgent rheumatology review within 2 weeks for diagnostic confirmation
Explanation: ***Commence prednisolone 40-60mg daily immediately and arrange same-day ophthalmology assessment*** - The patient's presentation with PMR-like symptoms (bilateral shoulder/hip girdle pain), constitutional symptoms (fever, weight loss), and markedly elevated inflammatory markers (**ESR 88, CRP 92**) in an elderly woman is highly suggestive of **Giant Cell Arteritis (GCA)**. - Immediate initiation of **high-dose corticosteroids** (prednisolone 40-60mg daily) is crucial to prevent irreversible **vision loss** or other ischemic complications, and same-day ophthalmology assessment is essential to evaluate for ocular involvement. *Start prednisolone 15mg daily and review response in 1 week* - A prednisolone dose of 15mg daily is appropriate for uncomplicated **Polymyalgia Rheumatica (PMR)**, but it is insufficient to prevent the potentially catastrophic ischemic complications of GCA. - Delaying appropriate **high-dose steroid** treatment for a week, especially in the presence of systemic symptoms, significantly increases the risk of **permanent blindness**. *Arrange urgent temporal artery ultrasound within 7 days* - While an **urgent temporal artery ultrasound** (looking for a **halo sign**) is a useful diagnostic tool for GCA, treatment with glucocorticoids should **never be delayed** for imaging studies. - A 7-day wait for an ultrasound is clinically unacceptable as GCA is a **medical emergency** requiring immediate intervention to prevent irreversible vascular damage. *Request urgent temporal artery biopsy before starting steroids* - **Temporal artery biopsy** is the gold standard for confirming GCA, but its performance should **not delay** the immediate administration of vision-saving corticosteroids. - Pathological features of GCA remain identifiable on biopsy for at least **1-2 weeks** after steroid initiation, allowing time for the biopsy after treatment has begun. *Request urgent rheumatology review within 2 weeks for diagnostic confirmation* - Waiting two weeks for a **rheumatology review** is far too long for suspected GCA, which requires **emergency management** due to the acute risk of severe complications. - Primary care clinicians should initiate **high-dose steroids** immediately upon suspicion of GCA, rather than awaiting specialist confirmation, to prevent **irreversible vision loss or stroke**.
Question 85: A 38-year-old woman presents with a 14-week history of widespread pain affecting her neck, shoulders, back, and thighs, associated with severe fatigue and unrefreshing sleep. Pain intensity fluctuates between 5-8/10. She also reports memory problems and frequent headaches. Examination shows multiple tender points but no joint swelling or neurological deficit. Blood tests including FBC, CRP, ESR, TFTs, CK, and vitamin D are all normal. Which additional assessment tool is most appropriate to support diagnosis and guide management?
- A. Brief Pain Inventory (BPI) to assess pain severity and interference with function
- B. Hospital Anxiety and Depression Scale (HADS) to screen for mood disorders
- C. Widespread Pain Index and Symptom Severity Score for fibromyalgia assessment (Correct Answer)
- D. Short Form-36 (SF-36) to measure health-related quality of life
- E. EuroQol-5D (EQ-5D) to evaluate overall health status
Explanation: ***Widespread Pain Index and Symptom Severity Score for fibromyalgia assessment*** - The patient's presentation with **chronic widespread pain** (neck, shoulders, back, thighs for 14 weeks), **severe fatigue**, **unrefreshing sleep**, **memory problems**, and **multiple tender points**, with normal inflammatory markers, is highly characteristic of **fibromyalgia**. - The **Widespread Pain Index (WPI)** and **Symptom Severity (SS) score** are the core components of the **2010/2016 American College of Rheumatology (ACR) diagnostic criteria** for fibromyalgia, directly assessing the required pain distribution and symptom severity. *Brief Pain Inventory (BPI) to assess pain severity and interference with function* - While the **Brief Pain Inventory (BPI)** is a valuable tool for quantifying **pain intensity** and its impact on daily activities, it is a general pain assessment and not specific enough to diagnose **fibromyalgia** based on its unique criteria. - It does not specifically assess the **widespread distribution of pain** or the severity of associated symptoms like fatigue and cognitive issues, which are central to a fibromyalgia diagnosis. *Hospital Anxiety and Depression Scale (HADS) to screen for mood disorders* - **Anxiety** and **depression** are common comorbidities in patients with fibromyalgia, and screening with **HADS** is often an important part of comprehensive management. - However, **HADS** is a screening tool for psychological distress and does not serve as a primary diagnostic instrument for the physical condition of **fibromyalgia** itself. *Short Form-36 (SF-36) to measure health-related quality of life* - The **Short Form-36 (SF-36)** is a generic health status questionnaire used to measure **health-related quality of life** across various domains, including physical and mental health. - While useful for tracking the overall impact of a chronic condition, it lacks the specificity to function as a diagnostic tool for **fibromyalgia**, which requires assessment of specific pain locations and symptom clusters. *EuroQol-5D (EQ-5D) to evaluate overall health status* - The **EuroQol-5D (EQ-5D)** is a standardized measure of **health status** and is often used in health economics and population studies to generate quality-adjusted life years (QALYs). - Similar to the SF-36, it provides a general overview of a patient's health but does not offer the detailed clinical criteria necessary for the specific diagnosis of **fibromyalgia**.
Question 86: A 71-year-old man presents with a 12-week history of lower back pain radiating to both legs, associated with difficulty walking more than 50 metres. The pain is worse when walking and relieved by sitting or leaning forward. He describes numbness in his feet and reports recent urinary hesitancy. Neurological examination shows preserved power but reduced sensation in L5/S1 distribution bilaterally and absent ankle reflexes. What is the most likely diagnosis?
- A. Lumbar spinal stenosis with neurogenic claudication (Correct Answer)
- B. Cauda equina syndrome requiring emergency imaging
- C. Peripheral arterial disease causing vascular claudication
- D. Degenerative lumbar disc disease with bilateral radiculopathy
- E. Diabetic polyneuropathy with associated mechanical back pain
Explanation: ***Lumbar spinal stenosis with neurogenic claudication*** - The patient exhibits classic **neurogenic claudication**, where leg pain and numbness are triggered by walking and specifically relieved by **sitting or leaning forward** (shopping cart sign), which increases the spinal canal diameter. - Clinical findings of **bilateral L5/S1 sensory loss** and **absent ankle reflexes** in an elderly patient further support chronic compression of the cauda equina nerve roots. *Cauda equina syndrome requiring emergency imaging* - This syndrome is a surgical emergency typically presenting with **acute urinary retention**, **saddle anesthesia**, and significant fecal incontinence or motor weakness, which are not acutely severe in this 12-week presentation. - While the patient has urinary hesitancy, the 12-week progression and **postural relief** are more characteristic of stable spinal stenosis than an acute, urgent cauda equina compression. *Peripheral arterial disease causing vascular claudication* - **Vascular claudication** is relieved simply by standing still and is not dependent on spinal posture (flexion), unlike neurogenic claudication. - It is usually associated with **diminished peripheral pulses** and skin changes, rather than the dermatomal sensory loss and absent reflexes seen in this case. *Degenerative lumbar disc disease with bilateral radiculopathy* - Lumbar disc herniation most commonly presents with **unilateral radiculopathy** (sciatica) and often worsens with spinal flexion, the opposite of this patient's presentation. - While it causes back pain, it does not typically produce the specific **claudicant pattern** where walking distance is consistently limited and relieved by bending forward. *Diabetic polyneuropathy with associated mechanical back pain* - **Diabetic neuropathy** usually presents with a "stocking-glove" distribution of sensory loss rather than the specific **L5/S1 nerve root distribution** observed. - It does not explain the mechanical symptoms of **claudication** or the immediate relief of symptoms upon leaning forward.
Question 87: A 52-year-old man with no significant medical history presents with a 6-week history of fever (documented temperatures 38.3-39.1°C), generalized myalgia, and a 5kg weight loss. Examination reveals no focal abnormalities. Initial blood tests show: Hb 108 g/L, WCC 11.2 x10⁹/L (neutrophils 8.1), CRP 78 mg/L, ESR 62 mm/hr. Blood cultures, urinalysis, and chest X-ray are normal. What is the most appropriate next investigation to arrange from primary care?
- A. Arrange urgent CT chest, abdomen and pelvis with contrast
- B. Request autoimmune screen including ANA, ANCA, and rheumatoid factor
- C. Refer urgently to infectious diseases for echocardiography
- D. Request HIV test, hepatitis serology, and QuantiFERON-TB Gold (Correct Answer)
- E. Arrange urgent whole body PET-CT scan
Explanation: ***Request HIV test, hepatitis serology, and QuantiFERON-TB Gold*** - This patient presents with characteristics of **Fever of Unknown Origin (FUO)**, including a 6-week fever (>38.3°C), systemic symptoms (myalgia, weight loss), and negative initial routine tests. - In primary care, a crucial next step in FUO is to systematically screen for common, treatable, and communicable infectious causes such as **HIV**, **viral hepatitis**, and **tuberculosis** through serology and specific tests like QuantiFERON-TB Gold. *Arrange urgent CT chest, abdomen and pelvis with contrast* - While **cross-sectional imaging** is a vital part of the FUO workup to detect occult sources like abscesses or malignancy, it typically follows an initial screen for common infectious diseases. - Ordering extensive imaging as a first step in primary care without ruling out basic infections may lead to unnecessary radiation exposure and could be less cost-effective. *Request autoimmune screen including ANA, ANCA, and rheumatoid factor* - **Autoimmune diseases** are common causes of FUO; however, an autoimmune screen is often performed after or concurrently with initial infectious disease screening, especially when specific clinical signs are absent. - These tests can lack specificity, and their interpretation can be challenging without additional **focal clinical findings** such as arthritis or rashes, which are not described in this patient. *Refer urgently to infectious diseases for echocardiography* - **Infective endocarditis** is a serious differential in FUO, but the patient has normal blood cultures, no new heart murmurs, and no other specific signs pointing towards cardiac involvement. - Urgent **echocardiography** is typically reserved for cases with higher suspicion, such as positive blood cultures, new valvular murmurs, or specific risk factors not present in this scenario. *Arrange urgent whole body PET-CT scan* - **PET-CT** is a highly sensitive imaging modality for identifying occult inflammation, infection, or malignancy, making it useful in complex FUO cases. - However, it is an advanced, expensive, and **specialist-led** investigation not typically performed as a first-line diagnostic test in primary care before basic infectious and inflammatory screens are completed.
Question 88: A 47-year-old woman presents with a 16-week history of profound fatigue, generalized aching, and cognitive difficulties ('brain fog'). Symptoms began after a documented COVID-19 infection. She has been unable to return to work. Examination and routine blood tests (FBC, U&E, LFTs, TFTs, CRP, glucose, ferritin) are all normal. She becomes breathless and experiences worsening fatigue for several days after minimal physical activity. What is the most appropriate management approach?
- A. Refer to cardiology for exercise tolerance testing and cardiac MRI
- B. Advise structured graded exercise programme starting with 10 minutes daily walking
- C. Recommend pacing strategies and energy management with avoidance of post-exertional symptom exacerbation (Correct Answer)
- D. Request CT pulmonary angiogram to exclude chronic thromboembolic disease
- E. Prescribe low-dose amitriptyline for fatigue and pain management
Explanation: ***Recommend pacing strategies and energy management with avoidance of post-exertional symptom exacerbation***- This patient presents with a classic picture of **Post-COVID-19 syndrome** (long COVID) characterized by **profound fatigue**, **cognitive difficulties**, and critically, **post-exertional symptom exacerbation (PESE)**, where symptoms worsen significantly after minimal physical activity.- **NICE guidelines (NG188)** for long COVID emphasize a **personalized, symptom-led approach** focusing on **pacing strategies** and energy management to stay within an "energy envelope" and prevent symptom flare-ups. *Refer to cardiology for exercise tolerance testing and cardiac MRI*- While **COVID-19** can affect the heart (e.g., **myocarditis**), this patient's normal clinical examination and routine blood tests make primary cardiac pathology less likely as the sole cause of widespread symptoms.- **Exercise tolerance testing** in a patient with **post-exertional malaise (PEM)** is contraindicated, as it can trigger severe and prolonged symptom exacerbation, worsening their condition. *Advise structured graded exercise programme starting with 10 minutes daily walking*- **Graded Exercise Therapy (GET)** is specifically *not* recommended and potentially harmful for patients experiencing **post-exertional symptom exacerbation (PESE)** in long COVID, as it can lead to a long-term decline in function.- Management should be **symptom-contingent** and aim to prevent overexertion rather than encouraging a fixed, incremental increase in activity. *Request CT pulmonary angiogram to exclude chronic thromboembolic disease*- Although **pulmonary embolism** is a potential complication post-COVID, this patient's generalized symptoms (fatigue, brain fog) and normal routine blood tests make a **CTPA** less indicated as a first-line investigation.- A **CTPA** involves significant radiation and is typically reserved for cases with stronger evidence of pulmonary vascular pathology, such as unexplained dyspnea with abnormal D-dimer or hypoxemia. *Prescribe low-dose amitriptyline for fatigue and pain management*- **Amitriptyline** may help with neuropathic pain or to aid sleep, but it does not directly address the core pathophysiology or management of **Post-COVID-19 fatigue** or cognitive impairment.- Pharmacological interventions for long COVID symptoms are generally considered **adjuncts** and should not replace the primary strategy of **activity management**, pacing, and multidisciplinary supportive care.
Question 89: A 36-year-old refugee from Sudan presents with a 10-week history of daily fever up to 38.9°C, 8kg weight loss, night sweats, and dry cough. He arrived in the UK 4 months ago. Chest examination reveals reduced breath sounds at the right apex. Chest X-ray shows right upper lobe consolidation with cavitation. What is the most appropriate immediate management while awaiting confirmation of diagnosis?
- A. Start standard quadruple anti-tuberculosis therapy and arrange respiratory isolation (Correct Answer)
- B. Prescribe amoxicillin 500mg three times daily for suspected community-acquired pneumonia
- C. Obtain three sputum samples for acid-fast bacilli and await results before treatment
- D. Refer urgently to respiratory medicine for same-day assessment and bronchoscopy
- E. Start rifampicin and isoniazid only pending culture and sensitivity results
Explanation: ***Start standard quadruple anti-tuberculosis therapy and arrange respiratory isolation*** - The patient presents with classic symptoms of **pulmonary tuberculosis (TB)**, including night sweats, weight loss, and **upper lobe cavitation**, necessitating immediate **quadruple therapy** (RIPE) due to high clinical suspicion. - **Respiratory isolation** is critical in the immediate management to prevent public health transmission, especially given the high risk of **infectivity** associated with cavitary disease. *Prescribe amoxicillin 500mg three times daily for suspected community-acquired pneumonia* - Amoxicillin is ineffective against **Mycobacterium tuberculosis** and is inappropriate for a presentation lasting 10 weeks with **cavitary lesions**. - This delay in correct treatment would allow for continued **disease progression** and potential community spread of TB. *Obtain three sputum samples for acid-fast bacilli and await results before treatment* - While **sputum samples** are essential for diagnosis, treatment should not be delayed in a highly symptomatic patient with **radiological evidence** of cavitation. - Awaiting results can take days for microscopy and weeks for **cultures**, increasing the risk of respiratory failure or transmission. *Refer urgently to respiratory medicine for same-day assessment and bronchoscopy* - **Bronchoscopy** is generally reserved for cases where sputum samples are negative but clinical suspicion remains, and is not the primary immediate step. - Immediate management involves starting **empirical treatment** and isolation rather than invasive procedures that may aerosolize the bacteria. *Start rifampicin and isoniazid only pending culture and sensitivity results* - Using only two drugs for active TB induction risks the development of **multi-drug resistance (MDR-TB)**. - Standard initial phase treatment requires **four drugs** (rifampicin, isoniazid, pyrazinamide, and ethambutol) to cover potential primary resistance.
Question 90: According to current NICE guidance, what is the recommended threshold for urgent direct access chest X-ray in adults presenting with unexplained weight loss in primary care?
- A. Any unexplained weight loss of more than 3kg in 3 months
- B. Unexplained weight loss combined with any respiratory symptoms
- C. Weight loss of 5% or more of body weight over 6 months
- D. Weight loss in patients aged 40 and over who have ever smoked (Correct Answer)
- E. Unexplained weight loss of more than 5kg in patients aged 50 and over
Explanation: ***Weight loss in patients aged 40 and over who have ever smoked*** - According to **NICE NG12 guidelines**, an urgent direct access **chest X-ray** (within 2 weeks) is recommended for individuals aged **40 years or older** with unexplained weight loss who have ever smoked. - This specific criterion targets a high-risk population for **lung cancer**, where unexplained weight loss can be an early and significant indicator. *Any unexplained weight loss of more than 3kg in 3 months* - NICE guidance for urgent direct access chest X-ray does not specify a **fixed numerical weight loss threshold** (e.g., 3kg) or a strict timeframe of 3 months. - While clinically relevant, this specific metric is not the **trigger for chest imaging** in the context of **lung cancer suspicion** under NICE NG12. *Unexplained weight loss combined with any respiratory symptoms* - While **respiratory symptoms** like cough, dyspnoea, or haemoptysis would increase suspicion, the NICE guidance allows for a direct access chest X-ray based solely on **age and smoking history** combined with unexplained weight loss. - The presence of respiratory symptoms would independently trigger referral pathways but is not a *necessary* condition when the **age and smoking** criteria are met. *Weight loss of 5% or more of body weight over 6 months* - This is a general clinical definition for **significant unintentional weight loss** and is often used in broader contexts of malignancy or chronic disease. - However, it is not the **specific criterion** outlined by NICE for urgent direct access chest X-ray in the context of **lung cancer screening** based on unexplained weight loss. *Unexplained weight loss of more than 5kg in patients aged 50 and over* - The **age threshold** for this specific NICE guideline is **40 years and over**, not 50 years. - Additionally, similar to other incorrect options, a specific **weight threshold (5kg)** is not the defining criterion in the **NICE NG12** guidance for urgent chest X-ray for unexplained weight loss.
Practice by Chapter
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free